Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
Muhtasari wa habari
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
Fuatilia habari za hivi karibuni kutoka kwa wachapishaji wanaoaminika pamoja na muhtasari mfupi. Fungua chanzo asili kwa maelezo.